The avant-pop singer on heartbreak album 'Michelangelo Dying,' leaning into chaos for inspiration, and 'very special city' SF ...

In NBC Select’s For What It’s Worth podcast, editors discuss the top shopping trends of 2026 across health, wellness, tech, ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Nestle NESN1.39%increase; green up pointing triangle recalled specific batches of its SMA baby formula, citing the potential presence of cereulide bacteria. The food-and-drink maker, also behind ...

Nestlé is facing a global health scandal, following the recall of a number of its infant formula products. The food and beverage giant issued the demand over concerns they contain a toxin which can ...

Nestlé has expanded a recall of infant formula to include more than 50 countries worldwide. Infant formula and follow-on formula have been recalled because of the potential presence of cereulide.

The testing was part of the state’s “Make America Healthy Again” commission. Katelyn Ferral is a politics reporter and a Report for America corps member. Contact her at [email protected]. Anyone ...

Florida is launching its own food testing program to check for contaminants like heavy metals and pesticides. Initial tests on 24 infant formulas found 16 contained heavy metals exceeding EPA safe ...

Nestle has issued a global recall of some baby formula products over concerns they contain a toxin which can cause food poisoning. The food and drink giant said specific batches of its SMA infant ...

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...